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Combinatorial chemistry has been with us for a long time, such that it has
brought several new ways of undertaking medicinal chemistry research
projects. Some undertakings include (i) the utilization of solid-phase
organic synthesis, (ii) the ability to carry out organic reactions in a parallel
manner, and (iii) the use of solid-supported reagents and catalysts. Over the
years, combinatorial chemistry has had a remarkable influence on devel-
oping new technical directions too (i.e. advanced instrumentation) in the
area of high-throughput analytical chemistry. In medicinal chemistry,
however, efforts are more geared towards speeding up the generation of
small molecules and subsequently bringing useful small molecules into the
medical arena.
As a combinatorial chemistry community, we have accomplished the pro-
duction of simple organic compounds in a high-throughput manner. In most
cases, these efforts have led to simple compounds, lacking the general
features that natural products offers. Due to the simple structures, combi-
natorial chemistry has certainly lacked broad interest and, thus, has not been
very successful in attracting global attention from the organic synthetic
community. Why this has been the case is a question we need to address!
In the past few decades, the field of organic synthesis has been a power-
house for generating new and smart methodologies leading to the efficient
synthesis of highly complex natural products. Progress in the area of
stereoselective and enantioselective organic synthesis has been phenom-
enal, and this knowledge has benefited the medicinal community tremen-
dously. It is crucial that the combinatorial chemistry community starts to
benefit from the advancements made in the past few decades in the area of
advanced organic synthesis. As a result, insight gained from organic
transformations is going to lead to the development of combinatorial
synthetic projects to obtain a rapid access to biologically relevant chemical
probes.
Since nature has been very successful in providing bioactive small-mole-
cule chemical probes (for example, alkaloids, flavonoids, terpenes and
polyether antibiotics) to the biological and medical community, these
compounds provide a stimulating direction to chemists interested in
developing small-molecule probes for dissecting cellular pathways. In
most cases, these compounds are rich in stereochemistry, rich in chiral
functional groups and possess three-dimensional architectures. These
features appear to be highly important in exhibiting selectivity to protein
binding and in differentiating closely related proteins. Several examples of
natural products have been used to dissect bio-macromolecular interactions
(protein–protein, protein–DNA/RNA) in a highly organized manner.
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Therefore, the inherent three-dimensional complex
nature of natural products is an intriguing property
that remains to be captured by the combinatorial
community.
From a historical perspective, the research efforts made in
classical combinatorial chemistry can be briefly outlined
in three phases:
1. In the early 1990s, the initial efforts in the
combinatorial chemistry arena were driven by the
improvements made in high-throughput screening
(HTS) technologies. This led to a demand for access
to a large set of compounds for biological screening.
To keep up with this growing demand, chemists were
under constant pressure to produce compounds in
vast numbers for screening purposes. For practical
reasons, the molecules in the first phase were simple
peptides (or peptide-like) and lacked the structural
complexity commonly found in modern organic
synthesis literature.
2. The second phase started in the late 1990s, when
chemists became aware that it is not just about
numbers; but something was missing in compounds
produced in a combinatorial fashion. Emphasis was
thus shifted towards quality rather than quantity.
3. Like the first phase, the third phase had its origin in
progress made by the biomedical community. As the
scientific community moved into the post-genomic
chemical biology age, there was a growing demand in
understanding the role of newly discovered proteins
and their interactions with other bio-macromolecules
(i.e. other proteins and DNA or RNA). For example,
the early goals of the biomedical research commu-
nity were centered on the identification of small-
molecule ligands for biological targets, such as G-
protein-coupled receptors (GPCRs) and enzymes.
However, the current challenges are moving in the
direction of understanding bio-macromolecular (i.e.
protein–protein, protein–DNA/RNA) interactions
and how small molecules could be utilized as useful
chemical probes in systematic dissection of these
interactions. By no means will this be a trivial
undertaking! The development of biological assays
towards understanding biomacromolecular interac-
tions is equally challenging as the need for having
access to useful small molecule chemical probes.
After working in the area of combinatorial chemistry for
some time, as a community, we asked ourselves how
society has benefited from embracing this field. We also
wanted to convey to the scientific community that com-
plexity in small molecules (serving as chemical probes)
will impact our understanding of the biological pathways
found in cellular systems such as the signaling pathways.
This special issue addresses these concerns in four dif-
ferent sections.
Section 1: Combinatorial chemistry
approaches to obtaining natural product
analogs
The article by Waldmann and co-workers strongly advo-
cates the need for staying close to natural products when
it comes to designing small-molecule chemical probes.
The rationale behind this philosophy is that natural
products have gone through the evolutionary process,
and thus serve as a useful guiding principle for developing
combinatorial chemistry programs.
Section 2: Diversity-oriented synthesis
approaches to obtaining natural product-like
compounds
Several leading research labs have contributed their views
and outlined their perspectives to this relatively new and
growing area within combinatorial chemistry. As men-
tioned earlier, the goal here is to develop combinatorial
chemistry programs that provide small-molecule chemi-
cal probes that are (i) rich in three-dimentional architec-
tures, (ii) rich in stereochemistry, and (iii) are either
natural product-directed or natural product-like. This
section begins with a contribution from Reayi and Arya
that clearly describes the challenges, advantages and
biological results in developing natural product-like small
molecule probes to be used as systematic chemical dis-
sectors of biomacromolecular interactions. By citing a few
examples from the literature on the use of natural pro-
ducts, the article also emphasizes the need for charting
the chemical space that is currently occupied by natural
products. A similar voice is also echoed by articles from
Shang and Tan and by Messer, Fuhrer and Ha¨ner, who
are advocates of using diversity-oriented synthesis to
obtain natural product-like compounds. Several examples
discussed in these two articles further validate the need
for developing such chemical probes in a high-throughput
manner.
In the next category, an article by Ulaczyk-Lesanko and
Hall nicely presents the growing use of multicomponent
reactions in producing libraries of complex natural deri-
vatives. The development of stereoselective, multicom-
ponent-based methods are in demand and we are going to
see a rise in this demand in coming years. On the other
hand, Beeler, Schaus and Porco Jr advocate the conver-
gent approaches to producing chemical libraries of hybrid
natural products. Several examples that utilize different
ligation-based strategies clearly testify the power of this
approach in rapidly generating complex small molecules.
Finally in this section, an article by Seitz and Reiser
focuses on developing diversity-oriented synthesis
approaches that are targeted to mapping the chemical
space around g-butyrolactones.
Section 3: Chemical vs biological space
An article from Roth has a different perspective on the
notion of diversity. Diversity is an element of function-
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ality where the response of diversity is measured by the
application of external criteria such as a biological assay.
The author asserts that a relevant diversity of chemical
structures, per se, does not exist.
An article from Haggarty nicely describes the need for
developing tools for better understanding the comple-
mentarity between chemical and biological spaces. With a
few examples of the recent work from the Broad Institute,
the use of several descriptors to understanding the che-
mical space and its relevance to the biological world is
outlined. The author also describes how this knowledge
could assist in developing chemical genomics program for
systematic understanding of the interactions of small
molecules with biological systems.
Spring and co-workers give an overview on the assessment
of structural diversity in combinatorial synthesis. Finally,
Selzer, Roth, Ertl and Schuffenhauer report their results
in finding a descriptor that describes the type of complex-
ity of chemical structures which is able to differentiate
between biological active and inactive compounds.
Section 4: The emerging biological
challenges; protein–protein interactions and
protein networking-based cell signaling
pathways
This section is aimed at outlining a few emerging
biological challenges and the desperate need for devel-
oping biologically relevant small molecule probes that
could help in understanding (and dissecting) complex
interactions. The editors of this issue are of the opinion
that the field of combinatorial chemistry has the poten-
tial to impact this area of research and hope that the
articles covered in the section will serve as a stimulating
biological direction for the newer generation of combi-
natorial chemists. For example, the article by Arkin
clearly outlines the need for developing small molecules
as modulators (inhibitor or promoter) of protein–protein
interactions. Protein–protein interactions are central to
protein networking-based cell-signaling events and their
modulation by small molecules provides a highly useful
starting point in understanding their roles in complex
cellular protein networking pathways. Because of the
dynamic and multiple roles of protein interactions in
networking pathways, the use of chemical tools (by
chemical genetic approaches) to modulate these inter-
actions in a systematic and reversible manner is very
much required. On the same level, an excellent over-
view by Johnson and co-workers describes protein net-
working machinery in MAPK kinases. These authors
also discuss the role of protein networking machinery in
organizing cellular signals and protein trafficking events.
The systematic chemical dissection of protein network-
ing pathways is likely to provide a better understanding
into its precise roles. At the same time, it offers a
challenging task for the combinatorial community to
develop small molecule-based programs that could assist
in dissecting such interactions in a highly organized
manner!
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